BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Covidien (COV) Unveils Expanded Recall of Brain Sensors


1/20/2012 8:51:26 AM

BOULDER, Colo., Jan 19, 2012 (BUSINESS WIRE) -- On November 8, 2011, Covidien initiated a voluntary recall of certain lots of its BIS(TM) Bilateral Sensors, due to a modification which inadvertently reversed the reference and left eye electrode. This modification could potentially cause a change in the performance of BIS monitoring systems when these sensors are used, resulting in the inaccurate calculation and presentation of processed EEG information for Bispectral Index(TM) (BIS), Density Spectral Array (DSA), and Asymmetry (ASYM) values.

To date, there have been no reports of patient injury related to the recalled products.

The voluntary recall only affects lot numbers manufactured during a specific period of time. Only BIS Bilateral Sensors from the 58 lot numbers listed below are affected by this action.

Customers were first notified about this issue by letter dated November 8, 2011. The Company has taken appropriate steps to address the issue, and adequate supplies of unaffected replacement product are available.

Customers should review product in inventory and current use to identify product from the affected lot codes and return affected lots to Covidien. To return the affected product for replacement product, contact Technical Services at 1-800-635-5267, option 3, then option 1, and reference the Return Goods Authorization (RGA) Number in the recall letter.

Healthcare professionals and customers may report adverse events or quality problems experienced with the use of this product to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, fax or by phone.

-- Online: www.fda.gov/medwatch/report.htm

-- Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm . Mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787

-- Fax: 1-800-332-0178

-- Phone: 1-800-332-1088

SOURCE: Covidien

Covidien

Rhonda Luniak, 303-406-8743

Vice President, Communications

Respiratory & Monitoring Systems

rhonda.luniak@covidien.com

or

Bruce Farmer, 508-452-4372

Vice President

Public Relations

bruce.farmer@covidien.com

or

Coleman Lannum, CFA, 508-452-4343

Vice President

Investor Relations

cole.lannum@covidien.com

or

Todd Carpenter, 508-452-4363

Director

Investor Relations

todd.carpenter@covidien.com



Read at BioSpace.com
Read at Wall Street Journal
Read at Fox News
Read at RTT News

Covidien
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES